(MENAFN- Coherent Market Insights) Blood flow measurement devices help in understanding the nature of blood flow such that the volume of blood supplied to various organs and abnormal changes in blood flow velocity. On the basis of products, these devices are divided into electromagnetic, laser Doppler, and ultrasonic Doppler blood flow meters.

Market Dynamics:
Increasing prevalence of peripheral vascular disease (PVD) combined with growing geriatric population is expected to augment the blood flow measurement devices market growth. For instance, around 6.5 million people age 40 and older in the United States have PVD, according to the Centers for Disease Control and Prevention (CDC).

Moreover, increasing research and development activities, as well as continuous advancements in the blood flow measurement devices are expected to propel the growth of the blood flow measurement devices market. For instance, in Jan. 2021, Valencell announced the development of an upgraded biometric blood pressure measuring technology for healthcare wearables that does not require calibration or a worn cuff.

Increasing prevalence of cardiovascular diseases and increasing adoption of innovative devices by the major players are also expected to fuel the growth of the market. For instance, in Jan. 2021, Sky Medical Technology announced that Luton and Dunstable University Hospital are the first NHS hospital in the South East to deploy the innovative geko device for VTE prevention in immobile acute stroke patients who cannot be prescribed the current standard of care.
Increasing clinical applications of blood flow measurement devices are expected to offer lucrative growth opportunities for players the market.

However, high cost of devices, stringent regulations, slow approval processes, and high investment for R&D and clinical trials are some of the factors expected to restrain the blood flow measurement devices market growth.

Competitive Analysis:
Key players operating in the blood flow measurement devices market are Compumedics Ltd., Carolina Medical Plc., Ace Medicals, Flowtronics Inc., Elcat GmBH, Cook Medical, D E Hokanson Inc., AKW Medicals Inc., Biomedix Inc, Medtronics, Transonic Systems, Perimed AB, Moor Instruments Ltd., Medistim ASA, GF Health Products, Deltex Medical Ltd., Arjo, Cook Medical Inc., Compumedics Ltd., and Atys Medical.

Key players in the market are focused on launch and approval of new devices to enhance their market presence or to strengthen their product portfolio. For instance, in January 2020, Cook Medical received FDA (Food and Drug Administration) authorization to market new EchoTip Insight Portosystemic Pressure Gradient Measurement System, an endoscopic ultrasound device to measure portal hypertension, in the United States.

MENAFN18022021005305011848ID1101622545